Alpha 2.0
Login Register
» Articles » PMID: 25535731

Enthusiasm for Cancer Screening in Great Britain: a General Population Survey

Overview
Journal Br J Cancer
Specialty Oncology
Date 2014 Dec 24
PMID 25535731
Citations 52
Authors
J Waller
K Osborne
J Wardle
Affiliations
Soon will be listed here.
Abstract

Background: With growing concerns about risk of harm from cancer screening, particularly from overdiagnosis, this study aimed to assess public attitudes to cancer screening in Great Britain.

Methods: We used a population-based survey to assess attitudes to cancer screening, screening history and demographic characteristics, in men and women aged 50-80 years. Data were collected using face-to-face computer-assisted interviews in 2012.

Results: In our sample of 2024, attitudes to cancer screening were overwhelmingly positive with almost 90% believing that screening is 'almost always a good idea' and 49% saying they would be tested for cancer even if it was untreatable. Attitudes were particularly positive among those who had previously taken part in breast or colorectal screening.

Conclusions: Our findings suggest that attitudes to cancer screening are very positive in Great Britain. Widespread enthusiasm for cancer screening may hamper attempts to encourage a greater appreciation of the limitations and potential harms of screening.

Citing Articles

Illness risk representations underlying women's breast cancer risk appraisals: A theory-informed qualitative analysis.

Woof V, McWilliams L, Evans D, Howell A, French D Br J Health Psychol. 2025; 30(2):e12792.

PMID: 40078028 PMC: 11904388. DOI: 10.1111/bjhp.12792.

Prostate Specific Antigen (PSA) testing in a general practice 2009-2019.

Maguire N, Moloney A, Fic K Ir J Med Sci. 2024; 194(1):1-3.

PMID: 39441509 DOI: 10.1007/s11845-024-03804-4.

Intention to have blood-based multi-cancer early detection (MCED) screening: a cross-sectional population-based survey in England.

Schmeising-Barnes N, Waller J, Marlow L Br J Cancer. 2024; 131(7):1202-1211.

PMID: 39191895 PMC: 11443085. DOI: 10.1038/s41416-024-02822-4.

Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in Japanese workplaces: a survey-based classification of enterprises' practices into "overscreening," "underscreening," and "guideline-adherence screening".

Minamitani M, Tatemichi M, Mukai T, Katano A, Ohira S, Nakagawa K BMC Public Health. 2024; 24(1):2223.

PMID: 39148101 PMC: 11325713. DOI: 10.1186/s12889-024-19775-1.

Understanding the Preferences and Considerations of the Public Towards Risk-Stratified Screening for Colorectal Cancer: Insights From Think-Aloud Interviews Based on a Discrete Choice Experiment.

Dennison R, Clune R, Morris S, Thomas C, Usher-Smith J Health Expect. 2024; 27(4):e14153.

PMID: 39030943 PMC: 11258464. DOI: 10.1111/hex.14153.

References
1.
Schwartz L, Woloshin S, Fowler Jr F, Welch H . Enthusiasm for cancer screening in the United States. JAMA. 2004; 291(1):71-8. DOI: 10.1001/jama.291.1.71. View
2.
Jorgensen K, Gotzsche P . Content of invitations for publicly funded screening mammography. BMJ. 2006; 332(7540):538-41. PMC: 1388137. DOI: 10.1136/bmj.332.7540.538. View
3.
Chapple A, Ziebland S, Hewitson P, McPherson A . Why men in the United Kingdom still want the prostate specific antigen test. Qual Health Res. 2008; 18(1):56-64. DOI: 10.1177/1049732307309000. View
4.
Entwistle V, Carter S, Trevena L, Flitcroft K, Irwig L, McCaffery K . Communicating about screening. BMJ. 2008; 337:a1591. DOI: 10.1136/bmj.a1591. View
5.
Gotzsche P, Hartling O, Nielsen M, Brodersen J, Jorgensen K . Breast screening: the facts--or maybe not. BMJ. 2009; 338:b86. DOI: 10.1136/bmj.b86. View